FDA Approves New Cholesterol-Lowering Pill

The Food and Drug Administration has approved a new pill designed to manage persistently high cholesterol levels. This approval introduces a more convenient option for patients who face a high risk of cardiovascular disease and heart attacks.

Unlike traditional cholesterol-lowering injections, Merck’s Lipfendra offers a daily oral alternative. This can simplify the treatment regimen for individuals struggling with high cholesterol, potentially improving adherence to prescribed therapies and overall heart health.